AnandRathi

Alivus Life Sciences Ltd Fundamental Analysis

Last Updated Date: 22 Sept 2026
₹1,373.55
-27.10 (-1.93%)

Alivus Life Sciences Ltd (Alivus Life) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹17,196 crore.

Alivus Life Sciences Ltd Overview

Market cap₹17,196 Crs
Volume6,222
Prev. Close₹1,400.65
Year range₹830.00 - ₹1,495.30
ISININE03Q201024

Alivus Life Sciences Ltd Fundamentals

ROCE(TTM)22.33%
P/E Ratio (TTM)28.51
P/B Ratio5.16
Debt to Equity0.02
ROE16.94%
EPS (TTM)50.64
Dividend Yield0.36%
Book Value271.41
Profit Margin24.00%
Operating Margin29.25%

Alivus Life Sciences Ltd Historical Performance

1 Month Return3.86%
6 Month Return47.61%
3 Year Return123.35%
3 Month Return29.39%
1 Year Return39.56%
5 Year Return102.95%

Alivus Life Sciences Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research